Application of mibefradil not only significantly suppressed HIF1 and 2 expressions, but also inhibited the AKT/mTOR pro-survival pathway associated with cancer, and induced signaling changes related to the induction of cell-cycle arrest and apoptosis [106]. The gene discussed is HIF1A; the disease is cancer.